Taheri, N.; Köhli, P.; Li, Z.; Wang, Z.; Vu-Han, T.-L.; Cloeren, K.; Koch, A.; Tsitsilonis, S.; Schömig, F.; Khakzad, T.;
et al. Risk-Adapted Use of Vancomycin in Secondary Scoliosis Surgery May Normalize SSI Risk in Surgical Correction of High-Risk Patients. J. Pers. Med. 2024, 14, 1017.
https://doi.org/10.3390/jpm14101017
AMA Style
Taheri N, Köhli P, Li Z, Wang Z, Vu-Han T-L, Cloeren K, Koch A, Tsitsilonis S, Schömig F, Khakzad T,
et al. Risk-Adapted Use of Vancomycin in Secondary Scoliosis Surgery May Normalize SSI Risk in Surgical Correction of High-Risk Patients. Journal of Personalized Medicine. 2024; 14(10):1017.
https://doi.org/10.3390/jpm14101017
Chicago/Turabian Style
Taheri, Nima, Paul Köhli, Zhao Li, Zhen Wang, Tu-Lan Vu-Han, Konstantin Cloeren, Antonia Koch, Serafeim Tsitsilonis, Friederike Schömig, Thilo Khakzad,
and et al. 2024. "Risk-Adapted Use of Vancomycin in Secondary Scoliosis Surgery May Normalize SSI Risk in Surgical Correction of High-Risk Patients" Journal of Personalized Medicine 14, no. 10: 1017.
https://doi.org/10.3390/jpm14101017
APA Style
Taheri, N., Köhli, P., Li, Z., Wang, Z., Vu-Han, T.-L., Cloeren, K., Koch, A., Tsitsilonis, S., Schömig, F., Khakzad, T., & Pumberger, M.
(2024). Risk-Adapted Use of Vancomycin in Secondary Scoliosis Surgery May Normalize SSI Risk in Surgical Correction of High-Risk Patients. Journal of Personalized Medicine, 14(10), 1017.
https://doi.org/10.3390/jpm14101017
